Caxton Associates (New York)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-8,742
Closed -$231K 575
2019
Q1
$231K Buy
+8,742
New +$231K 0.03% 304